Zimmer Biomet's Slump: Three Red Flags for Investors and a Safer Alternative
While the broader market rallies, medical device maker Zimmer Biomet has lagged, raising questions about its competitive edge and financial health. We examine the underlying challenges and highlight a more promising investment opportunity.